HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitory effects of rosiglitazone on paraquat-induced acute lung injury in rats.

AbstractAIM:
To investigate the effects of the PPAR-γ agonist rosiglitazone on acute lung injury induced by the herbicide paraquat (PQ) and the underlying mechanisms of action.
METHODS:
Male Sprague-Dawley rats were injected with PQ (20 mg/kg, ip). Rosiglitazone (3 or 10 mg/kg, ip) was administered 1 h before PQ exposure. Peripheral blood was collected at 4, 8, 24 and 72 h after PQ exposure for measuring the levels of MDA, TNF-α and IL-1β, and the SOD activity. Lung tissues were collected at 72 h after PQ exposure to determine the wet-to-dry (W/D) ratios and lung injury scores, as well as the protein levels of NF-κBp65, PPAR-γ, Nrf2, IκBα and pIκBα.
RESULTS:
At 72 h after PQ exposure, the untreated rats showed a 100% cumulative mortality, whereas no death was observed in rosiglitazone-pretreated rats. Moreover, rosiglitazone pretreatment dose-dependently attenuated PQ-induced lung edema and lung histopathological changes. The pretreatment significantly reduced the levels of TNF-α, IL-1β and MDA, increased SOD activity in the peripheral blood of PQ-treated rats. The pretreatment also efficiently activated PPAR-γ, induced Nrf2 expression and inhibited NF-κB activation in the lung tissues of PQ-treated rats. Furthermore, the pretreatment dose-dependently inhibited IκB-α degradation and phosphorylation, thus inhibiting NF-κB activation.
CONCLUSION:
Pretreatment with rosiglitazone protects rats against PQ-induced acute lung injury by activating PPAR-γ, inducing Nrf2 expression and inhibiting NF-κB activation.
AuthorsZhen-Ning Liu, Min Zhao, Qiang Zheng, Hong-Yu Zhao, Wei-Jian Hou, Shu-Ling Bai
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 34 Issue 10 Pg. 1317-24 (Oct 2013) ISSN: 1745-7254 [Electronic] United States
PMID23933652 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Herbicides
  • Interleukin-1beta
  • NF-E2-Related Factor 2
  • NF-kappa B
  • Nfe2l2 protein, rat
  • PPAR gamma
  • Thiazolidinediones
  • Tumor Necrosis Factor-alpha
  • Rosiglitazone
  • Malondialdehyde
  • Superoxide Dismutase
  • Paraquat
Topics
  • Acute Lung Injury (chemically induced, physiopathology, prevention & control)
  • Animals
  • Dose-Response Relationship, Drug
  • Herbicides (toxicity)
  • Interleukin-1beta (blood)
  • Male
  • Malondialdehyde (blood)
  • NF-E2-Related Factor 2 (genetics)
  • NF-kappa B (metabolism)
  • PPAR gamma (agonists)
  • Paraquat (toxicity)
  • Pulmonary Edema (physiopathology, prevention & control)
  • Rats
  • Rats, Sprague-Dawley
  • Rosiglitazone
  • Superoxide Dismutase (metabolism)
  • Thiazolidinediones (administration & dosage, pharmacology)
  • Time Factors
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: